Skip to main content
Top

Open Access 29-10-2024 | Arthritis | ORIGINAL ARTICLE

Structured and prompt treatment of early arthritis in clinical practice leverages window of opportunity and leads to excellent clinical outcomes: an innovative retrospective cohort study

Authors: R. L. Teixeira, R. da Silva Vieira, M. J. Saavedra, J. Polido-Pereira, R. A. Moura, I. Alcobia, J. E. Fonseca, V. C. Romão

Published in: Clinical Rheumatology

Login to get access

Abstract

Objectives

With this work, we evaluated the impact of the Lisbon Early ARthritis cliNic (LEARN) on untreated inflammatory arthritis clinical and patient-reported outcomes.

Methods

A retrospective cohort study enrolled patients in LEARN since its inception. Patients were followed for 12 months and treated to achieve disease remission. Clinical, structural, and quality of life outcomes were assessed. The early arthritis module of the Portuguese Rheumatic Diseases Registry (Reuma.pt) is described.

Results

We assessed 292 patients between 2015 and 2022. Mean symptom duration and DAS-28-4 V-ESR at baseline were 6.2 ± 3.5 months and 5.6 ± 1.3, respectively. Rheumatoid arthritis (56.4%; 40.1% seropositive) and psoriatic arthritis (12.4%) were the most common diagnoses. Most patients were treated with methotrexate (75.3%) combined with low-dose oral prednisolone (88.1%). At 12 months, a mean ΔDAS28-4 V-ESR improvement of 2.3 ± 0.4 was registered, with 29.5% and 48.9% of patients achieving remission (DAS28-4 V-ESR < 2.6) or low disease activity (DAS28-4 V-ESR < 3.2), respectively. Among RA patients only, these figures were 20.6% and 46.6%, respectively. A clinically meaningful functional improvement was observed in 72.1% of the patients. Structural progression was limited, affecting only 16.1% of the patients. Fatigue, anxiety, depression, and quality of life also improved substantially, translated by improvements in FACIT, HADS, EQ5D, and SF-36 scores.

Conclusions

A structured, dedicated approach to patients with early arthritis resulted in good clinical, structural, and functional outcomes. Furthermore, our findings suggest the window of opportunity for early intervention may have implications for mental health and global well-being.
Key Points
Patient assessment is facilitated by reliable electronic clinical records, such as the early arthritis module of the Rheumatic Diseases Portuguese Register (Reuma.pt) which we describe here for the first time.
Inflammatory arthritis was confirmed in the majority of patients observed, but the time to first appointment was above the recommended.
Prompt start of conventional therapy allowed significant disease activity improvement and remission to be achieved in about one-third of the patients.
Key patient-reported outcomes elucidate disease impact and confirm the benefit of early treatment initiation, suggesting a window of opportunity also for mental health and global well-being.
 
Appendix
Available only for authorised users
Literature
2.
go back to reference van Nies JAB, Krabben A, Schoones JW, Huizinga TWJ, Kloppenburg M, van der Helm-van Mil AHM (2014) What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis 73(5):861–870. https://doi.org/10.1136/annrheumdis-2012-203130 van Nies JAB, Krabben A, Schoones JW, Huizinga TWJ, Kloppenburg M, van der Helm-van Mil AHM (2014) What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis 73(5):861–870. https://​doi.​org/​10.​1136/​annrheumdis-2012-203130
5.
go back to reference Canhão H, Faustino A, Martins F, Fonseca JE (2011) Reuma.pt - the rheumatic diseases portuguese register. Acta Reumatol Port 36(1):45–56PubMed Canhão H, Faustino A, Martins F, Fonseca JE (2011) Reuma.pt - the rheumatic diseases portuguese register. Acta Reumatol Port 36(1):45–56PubMed
6.
go back to reference van Riel PLCM (2014) The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28). Clin Exp Rheumatol 32(5 Suppl 85):S-65–74 van Riel PLCM (2014) The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28). Clin Exp Rheumatol 32(5 Suppl 85):S-65–74
10.
go back to reference Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21(12):2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21(12):2286–2291PubMed
12.
go back to reference Gladman DD, Ibañez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288–291PubMed Gladman DD, Ibañez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288–291PubMed
17.
go back to reference Ferreira PL (2000) Development of the Portuguese version of MOS SF-36. Part I. Cultural and linguistic adaptation. Acta Med Port 13(1–2):55–66PubMed Ferreira PL (2000) Development of the Portuguese version of MOS SF-36. Part I. Cultural and linguistic adaptation. Acta Med Port 13(1–2):55–66PubMed
18.
go back to reference Ferreira PL (2000) Development of the Portuguese version of MOS SF-36. Part II –validation tests. Acta Med Port 13(3):119–127PubMed Ferreira PL (2000) Development of the Portuguese version of MOS SF-36. Part II –validation tests. Acta Med Port 13(3):119–127PubMed
21.
go back to reference Polido-Pereira J et al (2019) Portuguese recommendations for the use of ultrasound in rheumatology. Acta Reumatol Port 44(1):7–28PubMed Polido-Pereira J et al (2019) Portuguese recommendations for the use of ultrasound in rheumatology. Acta Reumatol Port 44(1):7–28PubMed
25.
go back to reference Fonseca JE (2013) Biobanco-IMM, Lisbon Academic Medical Centre: a case study. Acta Med Port 26(4):312–314CrossRefPubMed Fonseca JE (2013) Biobanco-IMM, Lisbon Academic Medical Centre: a case study. Acta Med Port 26(4):312–314CrossRefPubMed
30.
go back to reference Fonseca JE et al (2018) Effectiveness of a referral program for rheumatoid arthritis and axial spondyloarthritis diagnosis at primary care centers in Portugal - SIARA STUDY. Acta Reumatol Port 43(1):40–51PubMed Fonseca JE et al (2018) Effectiveness of a referral program for rheumatoid arthritis and axial spondyloarthritis diagnosis at primary care centers in Portugal - SIARA STUDY. Acta Reumatol Port 43(1):40–51PubMed
31.
go back to reference Mourão AF et al (2011) Markers of progression to rheumatoid arthritis: discriminative value of the new ACR/EULAR rheumatoid arthritis criteria in a Portuguese population with early polyarthritis. Acta Reumatol Port 36(4):370–376PubMed Mourão AF et al (2011) Markers of progression to rheumatoid arthritis: discriminative value of the new ACR/EULAR rheumatoid arthritis criteria in a Portuguese population with early polyarthritis. Acta Reumatol Port 36(4):370–376PubMed
32.
go back to reference Machold KP, Nell VP, Stamm TA, Eberl G, Steiner G, Smolen JS (2003) The Austrian early arthritis registry. Clin Exp Rheumatol 21(5 Suppl 31):S113–S117PubMed Machold KP, Nell VP, Stamm TA, Eberl G, Steiner G, Smolen JS (2003) The Austrian early arthritis registry. Clin Exp Rheumatol 21(5 Suppl 31):S113–S117PubMed
37.
go back to reference Gwinnutt JM et al (2018) Have the 10-year outcomes of patients with early inflammatory arthritis improved in the new millennium compared with the decade before? Results from the Norfolk arthritis register. Ann Rheum Dis 77(6):848–854PubMed Gwinnutt JM et al (2018) Have the 10-year outcomes of patients with early inflammatory arthritis improved in the new millennium compared with the decade before? Results from the Norfolk arthritis register. Ann Rheum Dis 77(6):848–854PubMed
Metadata
Title
Structured and prompt treatment of early arthritis in clinical practice leverages window of opportunity and leads to excellent clinical outcomes: an innovative retrospective cohort study
Authors
R. L. Teixeira
R. da Silva Vieira
M. J. Saavedra
J. Polido-Pereira
R. A. Moura
I. Alcobia
J. E. Fonseca
V. C. Romão
Publication date
29-10-2024
Publisher
Springer International Publishing
Published in
Clinical Rheumatology
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-024-07192-z

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Live: Wednesday 29th January, 18:00-19:30 CET

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more